Validation of an analytical method using HPLC-MS/MS to quantify osimertinib in human plasma and supplementary stability results
- Ard van Veelen
- , Robin van Geel
- , Yvo de Beer
- , Anne-Marie Dingemans
- , Leo Stolk
- , Rob Ter Heine
- , Frank de Vries
- , Sander Croes
- CARIM School for Cardiovascular Disease, Maastricht University Medical Center+, MD, Maastricht, the Netherlands.
- Department of Pulmonary Diseases, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands.
- Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Pharmacy, Nijmegen, the Netherlands.
Research output: Contribution to journal › Article › Academic › peer-review